Clinical Trials
6
Active:2
Completed:0
Trial Phases
2 Phases
Phase 1:4
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (66.7%)phase_1_2
1 (16.7%)Phase 2
1 (16.7%)A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
Phase 1
Recruiting
- Conditions
- Solid Tumor
- Interventions
- Biological: CLDN6 CAR-TBiological: CLDN6 uRNA-LPX/CLDN6 modRNA-LPX
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- BioNTech Cell & Gene Therapies GmbH
- Target Recruit Count
- 214
- Registration Number
- NCT04503278
- Locations
- 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇩🇪Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany
🇩🇪Universitätsklinikum Erlangen - Hämatologie & Intrinsische Onkologie - Medizinische Klinik 5, Erlangen, Germany
News
No news found